US$ 27.40
glp-1 drugs long term effects Common Weight-loss Side GLP-1R Agonists for Weight Loss
Description
Mounjaro (tirzepatide) Mounjaro was approved for the treatment of type 2 diabetes in 2022, and its also often prescribed off-label for weight loss

This initial dose establishes tolerance and reduces side effect incidence

NCSS, LLC
Common side effects include nausea, diarrhea, and vomiting while serious risks include thyroid cancer and kidney issues

Patients need to choose to pay $500 or more per month on their own
